RPhLink.com  The Pharmaceutical Care Network!

December  2002                                                                                         

    RPhLink - Your Express Link to a Pharmacist!

From: Elan Pharmaceutical:

Elan Pharmaceuticals, Inc. is proud to announce our acquisition of the US marketing rights to the entire immediate-release ROXICODONE product line, including ROXICODONE 15 mg and 30 mg tablets.

Elan is now supporting the full distribution and customer service for these products previously carried through Roxane Laboratories.  Effective immediately, all orders for Roxicodone should be placed through your wholesaler, and all sales to the pharmacies must be transacted through your wholesaler supply chain.

In addition:

We look forward to continuing to work with you to provide high-quality pain-management products, such as ROXICODONE 15 mg and 30 mg tablets, to your customers.  If you would like a sales representative to visit you or have further questions regarding a ROXICODONE order, please call 1-800-859-8586.

Oxycodone is a Schedule II drug that may cause tolerance as well as psychological and physical dependence.  The most serious risk associated with opiolds, including ROXICODONE, is respiratory depression.  In clinical trials (n=191), the most frequently observed adverse reactions (>3%) were nausea, constipation, vomiting, headache, pruritus, insomnia, dizziness.  ROXICODONE is contraindicated in patients with: known hypersensitivity to oxycodone; significant respiratory depression; acute or severe bronchial asthma or hypercarbia; and known or suspected paralycticileus.

ROXICODONE 5 mg tablets are indicated for the relief of moderate to moderately severe pain.  ROXICODONE 15 mg and 30 mg tablets are indicated for the relief of moderate-to-severe pain for patients who need opioid analgesics.

Please see the full Prescribing Information.

Sincerely,

Joseph Boudreau       

Vice President, Trade Relations                                                                                                                                               

Elan Pharmaceuticals, Inc.

PRODUCT

NDC

PACKAGE SIZE

ROXICODONE 5 mg Tablet  (oxycodone hydrochloride)

0054-8657-24                                 0054-4657-25

4 X 25                            Unit Dose        100 EA                              Bottle

ROXICODONE 15 mg Tablet  (oxycodone hydrochloride)

0054-8658-24                                 0054-4658-25

4 x 25                             Unit Dose        100 EA                              Bottle

ROXICODONE 30 mg Tablet  (oxycodone hydrochloride)

0054-8665-24                                   0054-4665-25

4 x 25                             Unit Dose       100 EA                              Bottle

ROXICODONE Oral Solution             5 mg/ 5 mL

0054-8782-16                                      0054-3682-63

5 mL  40s                           Bottle           500 mL                               Bottle

ROXICODONE Intensol                     20 mg/mL

0054-3683-44

30 mL                                 Bottle

Manufacturer:                                     Elan Pharmaceuticals, Inc. (with the addition of Dura Pharmaceuticals, Inc. Products)

Lot numbers and expiration dates are required for credit

Reimbursement Method:                    Checks issued to nondirect accounts

Reimbursement Dollar Limit:             Prior approval required for returns exceeding $5000 in value

Reimbursement Partial Policy:           Accepted and credited at 1/4 increments:                                                              Credit as % of $ value:                                                                                                                                                          0% - 24% = 0%                                                                                                                                                                  25% - 49% = 25%                                                                                                                                                               50% - 74% = 50%                                                                                                                                                                75% - 99% = 75%

Expiration Date Policy:                       Expired and within 12 months after expiration date

Other information:  


                                                     RPhLink Merchandise | Practice Tools | Pharmacy Vendors | Convention-Exhibits | Pharmacy Insurances | Next

  more news  |  discussions front page More News from Kinray| Previous News | Front Page!

General Pharmacy Classified | Pharmacy Antiques | Pharmacy Collectibles | Pharmacy Archives 

Front page | In Pharmacy this week | RxNews1 | RxNews2 | Pharmacy Jobs |

©2000 RPhLink.com - The Pharmaceutical Care Network! All Rights Reserved.